Thus, we used AC-YVAD-CMK to inhibit activity of caspase-1/IL-1β to further explore the mechanism of action of caspase-1/IL-1β in the pathogenesis of Alzheimer's disease. The gene discussed is IL1B; the disease is Alzheimer disease.